You are here
Award Data
The Award database is continually updated throughout the year. As a result, data for FY24 is not expected to be complete until March, 2025.
Download all SBIR.gov award data either with award abstracts (290MB)
or without award abstracts (65MB).
A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.
The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.
-
Development of Peptide Antibiotic Nucleic Acids
SBC: NUBAD LLC Topic: NIAIDDESCRIPTION provided by applicant One of the challenges of research in infectious diseases is to find ways to use the increasing knowledge of the mechanisms underlying disease transformation and progression to develop novel therapeutic strategies for diseases such as increasing menace of bacterial infections Targeting specific RNA such as rRNA which are involved in proliferation and survival ...
STTR Phase I 2014 Department of Health and Human ServicesNational Institutes of Health -
Ovarian cancer using novel nanoparticle formulations
SBC: KIROMIC BIOPHARMA INC Topic: 102DESCRIPTION provided by applicant Ovarian cancer is the fifth most leading cause of cancer related deaths in women in the US It has been observed that the cancer relapses within relatively short periods of time even after the surgery and chemotherapy Therefore immunotherapeutic strategies may serve as an alternative to control the recurrence or progression of ovarian cancer Oral vaccines ar ...
STTR Phase I 2014 Department of Health and Human ServicesNational Institutes of Health -
Optimized lactoferrin for treatment of intracerebral hemorrhage
SBC: Pharmareview Corporation Topic: NINDSDESCRIPTION provided by applicant Intracerebral hemorrhage ICH is a major public health problem with highest mortality rate of all stroke subtypes and long term disability Since there are no available FDA approved therapies for ICH it is of enormous importance to establish effective treatment for this medical condition Following ICH the deposited blood is damaging initially via compression ...
STTR Phase I 2014 Department of Health and Human ServicesNational Institutes of Health -
Uniform, High Intensity X-ray Source for Blood Irradiation
SBC: National Nanomaterials, Inc Topic: 22aThere is an ongoing effort to replace high activity radioactive sources that could pose a risk for use as terrorist weapons with non-radioisotope based technologies. Currently radioactive sources serve a number of critical needs including the treatment and diagnosis of disease, inspection and certification of critical mechanical structures, the sterilization of food and medical products, ...
STTR Phase I 2014 Department of Energy -
Next Generation Semiconductor-Based Radiation Detectors Using Cadmium Magnesium Telluride
SBC: BRIMROSE TECHNOLOGY CORP Topic: 23cAt present, CdZnTe is considered the material of choice for efficient, room temperature gamma-radiation detection systems used for the detection and identification of radionuclides. Despite the advances in CdZnTe materials technology during the last decade, the major impediments in the progress of - ray detection technology are the low yield of device quality materials and detectors, and the limit ...
STTR Phase I 2014 Department of Energy -
Optical Waveguide Cross-Correlator for Attosecond Timing Synchronization
SBC: ADVR, INC. Topic: 32cThis Phase I SBIR/STTR will establish the feasibility of developing a precision balanced optical cross-correlator using engineered nonlinear optical waveguides. The proposed device will be important for future advances at large scale accelerator facilities by providing a means to achieve long-term sub- femtosecond timing and synchronization of all of a facilitys optical and RF sub-systems over fib ...
STTR Phase I 2014 Department of Energy -
A Scalable Targeted Debugger for Scientific and Commercial Computing
SBC: ARGO NAVIS TECHNOLOGIES, LLC Topic: 02bWe propose to produce a commercial powerful lightweight debugging tool, called Swat, which will be of use to both supercomputer application programmers and to programmers of cluster- and cloud-based parallel e-commerce and engineering systems and middleware. The tool will be based the STAT stack-trace debugging tool produced jointly by the University of Wisconsin and Lawrence Livermore National La ...
STTR Phase I 2012 Department of Energy -
Treating EAE disease with Fc-Dimers
SBC: LeukoSight Inc Topic: NIAIDDESCRIPTION (provided by applicant): We have developed a recombinant polypeptide that we have termed Fc-Dimers (Di -mers). This product has potent anti-inflammatory activity in vitro, and we propose to test this reagent in an animal model of autoimmunedisease. We have selected the murine disease, Experimental Autoimmune Encephalomyelitis (EAE), a model for human multiple sclerosis (MS). Pathol ...
STTR Phase I 2012 Department of Health and Human ServicesNational Institutes of Health -
Chemical probes that target Stat3 to treat cancer
SBC: StemMed, Ltd. Topic: NCIDESCRIPTION (provided by applicant): We have shown for the first time in human breast cancer patients that residual tumors after standard chemotherapy are enriched for a CD44+/CD24-/low population of breast cancer stem or tumor-initiating cells (TIC) thatexhibit enhanced mammosphere-forming efficiency (MSFE) and display an increase in xenograft transplant outgrowths in mice (1, 2, 11). In addition ...
STTR Phase I 2012 Department of Health and Human ServicesNational Institutes of Health -
Using game mechanics to improve outcomes among stem cell transplant survivors
SBC: Radiant Creative Group, LLC Topic: NCIDESCRIPTION (provided by applicant Adolescent and young adult (AYA) hematopoietic stem cell transplantation (HSCT) patients face a variety of well-documented physical and emotional challenges. In addition to undergoing a life-threatening procedure that involves an intense treatment regimen and lengthy hospital stay, these patients face a protracted 12-month recovery period marked by numerous physi ...
STTR Phase I 2012 Department of Health and Human ServicesNational Institutes of Health